APA Zitierstil

Tabák, Á. G., Anderson, J., Aschner, P., Liu, M., Saremi, A., Stella, P., . . . Meier, J. J. (2019). Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis. Diabetes Ther.

Chicago Zitierstil

Tabák, Ádám G., John Anderson, Pablo Aschner, Minzhi Liu, Aramesh Saremi, Peter Stella, Francisco J. Tinahones, Carol Wysham, und Juris J. Meier. "Efficacy and Safety of IGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared With Basal-Bolus Regimen in Patients With Type 2 Diabetes: Propensity Score Matched Analysis." Diabetes Ther 2019.

MLA Zitierstil

Tabák, Ádám G., et al. "Efficacy and Safety of IGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared With Basal-Bolus Regimen in Patients With Type 2 Diabetes: Propensity Score Matched Analysis." Diabetes Ther 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.